Corporate Website
Africa
Argentina
Asia
Australia
Belgium
Brazil
Bulgaria
Canada (EN)
Chile
China
Colombia
Denmark
Egypt
France
Germany
Greece
Hungary
Indonesia
Italia
India
Japan
Korea
Malaysia
Mexico
Middle East
Netherlands
Peru
Philippines
Poland
Portugal
Romania
Russia
South Africa
Spain
Sweden
Thailand
Tunisia
Turkey
Ukraine
United Kingdom
USA
Vietnam
Your search for "piglet" return 16 results.
Tissue concentrations of amoxicillin in suckling piglets after single injection of Vetrimoxin® LA >
This study was conducted in order to evaluate the tissue concentration of amoxicillin in suckling piglet after injecting Vetrimoxin® LA
Compatibility of Coglapest® and Coglapix® vaccines in pigs >
This study was conducted in order to test the compatibility of Coglapix® and Coglapest® vaccines, when the latter was reconstituted in Coglapix®.
Comparison of vaccination with Coglapix® and targeted medication in the prevention of pleuropneumonia in pigs >
Antibiotics are frequently used for the mass repeated medication in growing and finishing phase to control pleuropneumonia. Current trend in pig farming is to reduce the overall use of antibiotics, pa...
Coglapest® >
Frequently Asked Questions
Clinical efficiency of Vetrimoxin® LA in the control of early mortality in suckling piglets >
Prophylactic use of efficient antibiotics can reduce the incidence of the disease and decrease the losses due to mortality or crushing of weak, sick piglets. The aim of this study was to evaluate the...
Efficacy of Coglapix® and Hyogen® vaccines in the Prevention of Pleuropneumonia and Enzootic Pneumonia >
The aim of this study was to compare the efficacy of Coglapix® - A.p toxoid vaccine (Ceva) and Hyogen® - M. hyo vaccine (Ceva) with competitor vaccines in the farm with the history of enzootic disease...
Overview of porcine immune defenses and immunity to Mycoplasma hyopneumoniae infection >
The pig relies on multiple defenses to protect itself against microbial invasion. Understanding these immune defenses will help the producers to find the suitable solution to control the diseases in p...
Mycoplasma hyopneumoniae: strain diversity and control measures >
Control measures for infections with Mycoplasma hyopneumoniae should focus on optimisation of management practices, and if these are not sufficient, antimicrobial medication and/or vaccination can be...
Coglapix® - Economic benefit study versus an antibiotic in the control of A.P. >
The Vaccine group (with Coglapix®) and Antibiotic group have the higher performance and more profit than the Control group. Although the similar performance, the economic impact given by the Vaccine g...
Mycoplasma hyopneumoniae - still a major challenge >
Mycoplasma hyopneumoniae cannot be ignored warns JOHN BAKER. Vaccination provides immediate improvement in the control of this costly disease and correcting problems in environment and management will...